VS

Vijay Shankar Pal

Active Director Director DIN 08531140
DIN 08531140 First appointment Aug 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Vijay Shankar Pal

Data last updated:

Vijay Shankar Pal is a Director at Ry Pharma Private Limited (since 2019). The company operates in Chemicals. Ry Pharma Private Limited reported revenue of ₹5.9 Lakh (FY 2024).

DIN 08531140
Primary Designation Director
Industry Chemicals
First Appointment 06 Aug 2019
Oldest Company Age 7 yrs
Largest company Ry Pharma Private Limited · ₹5.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ry Pharma Private Limited U24100UP2019PTC119919
Director06 Aug 20192019₹5.9 Lakh (FY 2024)Active

Board colleagues of Vijay Shankar Pal

NameDINCompanyDesignation
Pragati Singh08616955Ry Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ry Pharma Private Limited
Premium access

Shareholding and investment profile for Vijay Shankar Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Shankar Pal

Vijay Shankar Pal currently holds 1 directorship: Ry Pharma Private Limited (Director, since 06 Aug 2019, revenue ₹5.9 Lakh (FY 2024)).

Vijay Shankar Pal was first appointed on 06 Aug 2019 as Director at Ry Pharma Private Limited.

The current boards of Vijay Shankar Pal's companies include Pragati Singh (Ry Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available